Search Results for 'Erlotinib'

Erlotinib published presentations and documents on DocSlides.

Acquired Resistance Patient Forum
Acquired Resistance Patient Forum
by test
September 6, 2014 | Boston. In ALK, ROS1 & EG...
EGFR Mutation in  Lung Adenocarcinoma (ADC)
EGFR Mutation in Lung Adenocarcinoma (ADC)
by QuietConfidence
Ana Rima. Lung Cancer: Incidence and Mortality. Ne...
Mechanistic Insights into Oncogenic Activation of Epidermal
Mechanistic Insights into Oncogenic Activation of Epidermal
by ripplas
Growth Factor Receptor (EGFR) mutants and its Clin...
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
by pasty-toler
This program will include a discussion of off-lab...
Defining Epidermal Growth Factor Receptor exon 20 mutant se
Defining Epidermal Growth Factor Receptor exon 20 mutant se
by trish-goza
k. inase . i. nhibition. Danny Rayes . Lung Cance...
Defining Epidermal Growth Factor Receptor exon 20 mutant se
Defining Epidermal Growth Factor Receptor exon 20 mutant se
by danika-pritchard
k. inase . i. nhibition. Danny Rayes . Epidermal ...
Best Practices in Nursing Management of EGFR Inhibitor Rash
Best Practices in Nursing Management of EGFR Inhibitor Rash
by olivia-moreira
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pr...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Mechanisms of resistance to EGFR
Mechanisms of resistance to EGFR
by conchita-marotz
TKI. s. . and . related. . treatment . strategi...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...